Events An annual Corporate Partnership Programme meeting provided a forum for EMBL researchers and industry representatives to discuss mobile labs, planetary biology, and other areas of common interest.
2023
events
Announcements, Science Open Targets, a consortium focused on drug target identification, prioritisation, and validation, announced today that Pfizer has joined as a partner.
2022
announcementsscience
Science EMBL researchers, in collaboration with BD Biosciences, have demonstrated a new technology that allows rapid image-based sorting of cells. The new technology represents a major upgrade to flow cytometry and has applications in diverse life science fields.
2022
science
Science RNA vaccines, such as the ones for COVID-19, represent a new approach in vaccine technology. Cy Jeffries, faculty staff scientist at EMBL Hamburg, explains the clever technology behind RNA vaccines, and how structural biology contributes to its development. EMBL Hamburg collaborated on several…
2021
science
Lab Matters Independent impact review finds EMBL experimental services are ‘critical’ for research and endorses EMBL as a world-class service provider for academia and industry.
2021
lab-matters
Science Researchers establish a framework for identifying new drugs capable of exploiting a cell’s own machinery.
2021
science
Lab Matters EMBL’s EU Green Week event showcased various ways molecular biology research can help solve environmental challenges.
2021
lab-matters
Science Scientists have determined the structure of Glycine Transporter 1. The finding could open new avenues for developing therapeutics for psychiatric disorders
2021
science
Science Biotechnology company BioNTech and Johannes Gutenberg University Mainz conduct collaborative research with EMBL scientists at the beamline P12 in Hamburg
2020
science
Lab Matters The European Molecular Biology Laboratory has secured 6.8 million Euros funding from the European Commission to launch a unique training programme. The ARISE Programme will train and develop Europe’s next generation leadership for research infrastructures in the life sciences.
2020
lab-matters
Lab Matters EIPOD4 will prepare researchers for the increasing interdisciplinarity of scientific career paths
2019
lab-matters
Lab Matters Building bonds between academia and industry
2019
lab-matters
Lab Matters Joining forces to advance training in biomedical research and therapy
2019
lab-matters
Science EMBL-EBI industry case study: Biocatalysts
2018
science
Events EMBL postdocs discover industry-led research opportunities at the Corporate Summer School
2018
events
Lab Matters Pharmaceutical company Sanofi strengthens drug targets discovery collaboration Open Targets
2018
lab-matters
Lab Matters EMBL and Promega collaborate to train young scientists
2018
lab-matters
Lab Matters The ATTRACT initiative, of which EMBL is a partner, has launched an open call for seed funding
2018
lab-matters
Lab Matters Roche and EMBL join forces
2018
lab-matters
Lab Matters EMBL-EBI PhD student launches start-up focusing on epigenetics and wellbeing
2018
lab-matters
Lab Matters New partner strengthens drug discovery collaboration
2018
lab-matters
Lab Matters New EMBL spinoff company Velabs Therapeutics aims to speed up discovery of therapeutic antibodies
2018
lab-matters
Lab Matters Joining forces for single-cell research
2018
lab-matters
Lab Matters Takeda joins pioneering public-private drug discover collaboration Open Targets
2017
lab-matters
Lab Matters EMBL and HeidelbergCement sign Memorandum of Understanding
2017
lab-matters
Events Exploring the potential of user experience for life sciences through industry workshops
2017
events
Lab Matters Accelerating researchers’ access to next-generation light-sheet microscopy
2017
lab-matters
Alumni EMBL alumnus Joep Muijrers talks about making the transition from science into business
2017
alumni
Science Side-effects of leukaemia drug explained, reveal possibility of repurposing to treat other diseases
2016
science
Events Alumnus and entrepreneur Marc Zabeau speaks at inaugural Life Science Funders and Foundations event
2016
events
Alumni Abel Ureta-Vidal and Louise Modis join colleagues and peers at gathering of UK-based alumni
2016
alumni
Lab Matters Pioneering target validation collaboration expands to accelerate drug discovery research.
2016
lab-matters
Science Protein screens developed at EMBL Hamburg now commercially available
2016
science
Lab Matters Identifying evidence-based relationships between drug targets and diseases.
2015
lab-matters
Lab Matters EI3POD: flagship interdisciplinary postdoc programme opens its doors to academia and industry.
2015
lab-matters
Events Industrial partners and BioStruct-X facility members gather for Workshop at EMBL Hamburg.
2015
events
Alumni Career insights from Riccardo Cortese, whose start-up is developing an Ebola vaccine candidate.
2015
alumni
Alumni Alumni in senior positions in industry share career challenges, highlights and EMBL’s continuing role.
2015
alumni
Events EMBL’s corporate partners zoom in on big data and bioimaging.
2015
events
Events Life Science Nord event reveals how pharmaceutical companies use synchrotrons for their research.
2014
events
Lab Matters As the Lab turns 40, staff and alumni share 40 things that make EMBL, EMBL
2014
lab-matters
Alumni Two EMBL alumni, each developing community-led tools to support life science research
2014
alumni
Lab Matters A new EMBL-EBI biomedical initiative works to determine the best target proteins for new drugs.
2014
lab-matters
Lab Matters The European Commission has awarded 3.7 Million Euro under the European Union Framework 6 Programme over the next four years to a new Marie Curie Research Training Network, coordinated by Dr. Andreas Ladurner at the European Molecular Biology Laboratory (EMBL). The long molecules of DNA that carry…
2007
lab-matters
Lab Matters Today EMBL scientists, EMBL’s commercial affiliate, EMBL Enterprise Management Technology Transfer GmbH (EMBLEM) and EMBL’s venture vehicle, EMBL Ventures GmbH, announce the foundation of Elara Pharmaceuticals GmbH, a start-up company that will translate basic research findings into new…
2006
lab-matters
No matching posts found
Looking for past print editions of EMBLetc.? Browse our archive, going back 20 years.
EMBLetc. archive